CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets
Cash	$ 14,636,602	$ 3,551,832
Prepaid drug product for testing	96,563	51,364
Other current assets	194,181	64,117
Total current assets	14,927,346	3,667,313
Fixed assets	66,124	0
Other assets
Technology licenses - related party	2,500,374	2,500,374
Less Accumulated Amortization	(1,209,325)	(1,088,856)
Intangible Assets, Net (Excluding Goodwill), Total	1,291,049	1,411,518
TOTAL ASSETS	16,284,519	5,078,831
Current liabilities
Accounts payable	88,514	76,109
Accrued expense	77,594	66,739
Accrued expense - related party	67,050	52,050
Accrued license payments - related party	50,000	100,000
Total current liabilities	283,158	294,898
Long term debt	0	0
TOTAL LIABILITIES	283,158	294,898
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 9/30/14 and 12/31/13, respectively	89,238	84,238
Additional paid in capital	34,231,482	20,096,991
Accumulated deficit	(18,319,359)	(15,397,296)
Total shareholders' equity	16,001,361	4,783,933
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	$ 16,284,519	$ 5,078,831